About Eps international
EPS International: A Global CRO with SRO Capabilities
EPS International is a leading Contract Research Organization (CRO) that specializes in providing clinical research services to pharmaceutical, biotechnology, and medical device companies. With its headquarters in the United States, EPS International has a global presence with offices in Asia and Europe.
The company's core focus is on conducting clinical trials for new drugs and medical devices. EPS International has extensive experience in managing all phases of clinical trials from Phase I to Phase IV. The company's expertise lies in conducting trials across multiple therapeutic areas such as oncology, cardiology, neurology, infectious diseases, and more.
EPS International's unique selling proposition is its Site Management Organization (SMO) capabilities. The company has established partnerships with leading hospitals and clinics across Asia to conduct clinical trials efficiently. This allows EPS International to provide end-to-end solutions for its clients by managing the entire trial process from site selection to patient recruitment.
The company's therapeutics services are designed to help bring new drugs to market quickly. EPS International provides a range of services such as protocol development, regulatory affairs support, data management & biostatistics analysis, medical writing & publication support.
EPS international also offers consulting services that help clients navigate complex regulatory environments across different geographies. The company provides guidance on regulatory compliance requirements for drug development programs globally.
EPS international prides itself on being an innovative CRO that leverages technology solutions such as electronic data capture (EDC), interactive voice response systems (IVRS), and electronic patient-reported outcomes (ePROs). These technologies enable efficient data collection during clinical trials while ensuring patient safety and privacy.
In conclusion,
EPS international is a global CRO with SMO capabilities that conducts clinical trials across multiple therapeutic areas in Asia. The company's therapeutics services help bring new drugs to market quickly by providing end-to-end solutions for its clients' drug development programs globally. With its innovative approach and technology solutions, EPS international is well-positioned to continue its growth trajectory in the clinical research industry.